Penumbra Inc
(STU:0P8)
€
212.2
2.5 (1.19%)
Market Cap: 8.20 Bil
Enterprise Value: 8.14 Bil
PE Ratio: 266.87
PB Ratio: 7.97
GF Score: 87/100 Penumbra Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019 / 08:00PM GMT
Release Date Price:
€120.56
(+8.55%)
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research
I'm going to kick off the afternoon with Penumbra. I'm Bob Hopkins from BofA. I think at this point after 4 years, 5 years, you've been here with the company. Everybody knows Adam and Sri. Very thankful to have you guys here. We'll just have a good conversation. Adam, I don't know if there's any kind of quick intro you wanted to give or we get right into questions?
Adam Elsesser
Penumbra, Inc. - Co Founder, Chairman, CEO & President
Get right into it.
Questions & Answers
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research
Great. So obviously, you guys just reported earnings. And maybe just reflecting on the quarter and some of the moving pieces, what do you think are the kind of the 1 or 2 things that you really wanted people to notice from your first quarter?
Adam Elsesser
Penumbra, Inc. - Co Founder, Chairman, CEO & President
Well, so we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot